Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders
- PMID: 35277974
- DOI: 10.1111/head.14282
Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders
Abstract
Indomethacin-responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches. Many patients show a rapid therapeutic response to indomethacin, which is limited by intolerability. Etoricoxib and celecoxib, selective inhibitors of cyclo-oxygenase-2 (COX-2), spare gastroduodenal COX-1 activity and are less likely to cause gastrointestinal adverse effects than indomethacin. We report a case series of eight patients, seven who responded to etoricoxib and one patient who responded to celecoxib.
Keywords: celecoxib; cyclo-oxygenase-2 inhibitors; etoricoxib; indomethacin-responsive headache disorders.
© 2022 American Headache Society.
Similar articles
-
Indomethacin-responsive headaches.Curr Neurol Neurosci Rep. 2015;15(2):516. doi: 10.1007/s11910-014-0516-y. Curr Neurol Neurosci Rep. 2015. PMID: 25467407 Review.
-
Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis.BMJ Open. 2020 Sep 10;10(9):e036748. doi: 10.1136/bmjopen-2019-036748. BMJ Open. 2020. PMID: 32912981 Free PMC article.
-
Indomethacin-responsive headache syndromes.Curr Pain Headache Rep. 2004 Feb;8(1):19-26. doi: 10.1007/s11916-004-0036-6. Curr Pain Headache Rep. 2004. PMID: 14731379 Review.
-
Indomethacin-responsive headaches-A narrative review.Headache. 2021 May;61(5):700-714. doi: 10.1111/head.14111. Headache. 2021. PMID: 34105154 Review.
-
Are Cox-2 drugs the second line option in indomethacin responsive headaches?J Headache Pain. 2010 Oct;11(5):405-7. doi: 10.1007/s10194-010-0225-0. Epub 2010 Jun 2. J Headache Pain. 2010. PMID: 20517705 Free PMC article.
Cited by
-
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?Curr Opin Neurol. 2025 Jun 1;38(3):254-261. doi: 10.1097/WCO.0000000000001347. Epub 2025 Feb 5. Curr Opin Neurol. 2025. PMID: 39911098 Free PMC article. Review.
-
Merging konjac glucomannan with other copolymeric hydrogels as a cutting-edge liquid raft system for dual delivery of etoricoxib and famotidine.Drug Deliv. 2023 Dec;30(1):2189630. doi: 10.1080/10717544.2023.2189630. Drug Deliv. 2023. PMID: 36927148 Free PMC article.
References
REFERENCES
-
- Bahra A. Other primary headaches-thunderclap-, cough-, exertional-, and sexual headache. J Neurol. 2020;267(5):1554-1566. doi:10.1007/s00415-020-09728-0
-
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1-211. doi:10.1177/0333102417738202
-
- VanderPluym J, Indomethacin-responsive headaches. Curr Neurol Neurosci Rep. 2015;15:516. doi:10.1007/s11910-014-0516-y
-
- Pareja JA, Ruiz J, de Isla C, et al. Idiopathic stabbing headache (jabs and jolts syndrome). Cephalalgia. 1996;16(2):93-96. doi:10.1046/j.1468-2982.1996.1602093.x
-
- Lucas S. The pharmacology of indomethacin. Headache. 2016;56(2):436-446. doi:10.1111/head.12769
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials